http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#Head http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#assertion http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#provenance http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#pubinfo http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#assertion http://purl.obolibrary.org/obo/DOID_11103 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_11103 http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00254 http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association http://www.w3.org/2000/01/rdf-schema#label doryx mpc is a tetracycline class drug indicated for rickettsial infections 1 1 sexually transmitted infections 1 2 respiratory tract infections 1 3 specific bacterial infections 1 4 ophthalmic infections 1 5 anthrax including inhalational anthrax post exposure 1 6 alternative treatment for selected infections when penicillin is contraindicated 1 7 adjunctive therapy in acute intestinal amebiasis and severe acne 1 8 prophylaxis of malaria 1 9 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of doxycycline hyclate doryx mpc and other antibacterial drugs doryx mpc tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria 1 1 doryx mpc is indicated for treatment of rocky mountain spotted fever typhus fever and the typhus group q fever rickettsialpox and tick fevers caused by rickettsiae doryx mpc is indicated for treatment of the following sexually transmitted infections uncomplicated urethral endocervical or rectal infections in adults caused by chlamydia trachomatis nongonococcal urethritis caused by ureaplasma urealyticum lymphogranuloma venereum caused by chlamydia trachomatis granuloma inguinale caused by klebsiella granulomatis uncomplicated gonorrhea caused by neisseria gonorrhoeae chancroid caused by haemophilus ducreyi doryx mpc is indicated for treatment of the following respiratory tract infections respiratory tract infections caused by mycoplasma pneumoniae psittacosis ornithosis caused by chlamydophila psittaci because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline culture and susceptibility testing are recommended doxycycline is indicated for treatment of infections caused by the following microorganisms when bacteriological testing indicates appropriate susceptibility to the drug haemophilus influenzae klebsiella streptococcus pneumoniae doryx mpc is indicated for treatment of the following specific bacterial infections relapsing fever due to borrelia recurrentis plague due to yersinia pestis tularemia due to francisella tularensis cholera caused by vibrio cholerae campylobacter fetus infections caused by campylobacter fetus brucellosis due to brucella bartonellosis due to bartonella bacilliformis because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline culture and susceptibility testing are recommended doryx mpc is indicated for treatment of infections caused by the following gram negative microorganisms when bacteriological testing indicates appropriate susceptibility to the drug escherichia coli enterobacter aerogenes shigella species acinetobacter species urinary tract infections caused by klebsiella species doryx mpc is indicated for treatment of the following ophthalmic infections trachoma caused by chlamydia trachomatis inclusion conjunctivitis caused by chlamydia trachomatis doryx mpc is indicated for treatment of anthrax due to bacillus anthracis bacillus anthracis doryx mpc is indicated as an alternative treatment for the following selected infections when penicillin is contraindicated syphilis caused by treponema pallidum yaws caused by treponema pallidum pertenue listeriosis due to listeria monocytogenes vincent s infection caused by fusobacterium fusiforme actinomycosis caused by actinomyces israelii infections caused by clostridium in acute intestinal amebiasis doryx mpc may be a useful adjunct to amebicides in severe acne doryx mpc may be useful adjunctive therapy doryx mpc is indicated for the prophylaxis of malaria due to plasmodium falciparum see dosage and administration 2 2 patient counseling information 17 to reduce the development of drug resistant bacteria and maintain the effectiveness of doryx mpc and other antibacterial drugs doryx mpc should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00254 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#provenance http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#pubinfo http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig http://purl.org/nanopub/x/hasSignature Ct8bQcp8x4SI9tZSOoKiVoZ33sjRfT3ZbcNhhz42NPwJIAJ0WpZENX2MTeqXw/UXSEyRCT1iCUGBtNcN4MfZDsdPXsHEQ6p2mHHgL5flBNb/QZiCUY0tFRXd4EgyaR3nElWApzFunVN5btf4epXzWUFehA5d8KPvgnFm1jkbvMY= http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g http://purl.org/dc/terms/created 2021-06-29T08:17:11.228+02:00 http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs